Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 29.66 --0 (-0%)
Previous Close $29.66    52 Week High
Open $29.66    52 Week Low
Day High $29.66    P/E N/A 
Day Low $29.66    EPS
Volume 6,101